Instructions for Polygynax
Release form Polygynax:
vaginal capsules Polygynax
Owner / Registrar Polygynax:
- Laboratoire INNOTECH INTERNATIONAL
- International Classification of Diseases (ICD-10) B37.3
- Vulvar and vaginal candidiasis (N77.1 *) N72
- Inflammatory disease of the cervix N76
- Other inflammatory diseases of the vagina and vulva Z29.2
- Another type of preventive chemotherapy
Pharmacological group Polygynax:
Drug with antibacterial and antifungal action for local use in gynecology
pharmachologic effect Polygynax:
A drug Polygynax with antibacterial and antifungal action for local use in gynecology. Has a bactericidal effect.
and
B are active against many gram-positive and gram-negative microorganisms. Streptococcus spp. and anaerobic bacteria are insensitive to these antibiotics.
has a fungicidal effect against Candida fungi.
The drug improves trophic processes in the vaginal mucosa.
Pharmacokinetics Polygynax:
It is evenly distributed on the mucous membrane of the vagina, providing a local bactericidal and fungicidal effect. Practically not absorbed from the surface of the vaginal mucosa.
THERE ARE CONTRAINDICATIONS, BEFORE USING IT IS NECESSARY TO CONSULT A SPECIALIST
Possible: allergic reactions, burning, itching, irritation in the vagina; allergic contact erythema.
With prolonged use, a systemic manifestation of side effects of aminoglycosides is possible.
Antibacterial antifungal indications:
Treatment of infectious and inflammatory diseases caused by sensitive microorganisms:
nonspecific vaginitis;
fungal vaginitis, mixed vaginitis
vulvovaginitis, cervicovaginitis
Prophylaxis with the drug in infectious and inflammatory diseases.
Before genital surgery
Before and after diathermocoagulation of the cervix in women.
Before intrauterine diagnostic procedures and childbirth.
Overdose Polygynax:
Currently, no cases of an overdose of Polygynax have been reported.
special instructions
Before using the drug, it is necessary to take a preliminary smear and conduct a bacteriological analysis.
The terms of use of the drug should be limited in order to prevent the formation of resistance to it of individual pathogens and the risk of reinfection.
It is not recommended to use latex caps and condoms during treatment.
You should not interrupt the course of treatment during menstruation.
The patient should be warned about the need to inform the attending physician about the aggravation of any of the side effects indicated in the instructions or about the occurrence of other side effects not specified in the instructions.
Influence on the ability to drive vehicles and use mechanisms
There is no data on the negative effect of the drug on the ability to drive vehicles and other mechanisms.
Application during pregnancy and lactation Polygynax:
The use of the drug in the first trimester of pregnancy is contraindicated.
Application in the II and III trimesters of pregnancy is possible only as directed by a doctor in cases where the expected benefit to the mother outweighs the potential risk to the fetus.
Use during lactation is contraindicated. If necessary, use the drug during this period, breastfeeding should be discontinued.
Drug interactions Polygynax:
It is not recommended to use Polygynax simultaneously with spermicides, because a decrease in the activity of the drug is possible.
THERE ARE CONTRAINDICATIONS, BEFORE USING IT IS NECESSARY TO CONSULT A SPECIALIST
How to take Polygynax:
Lying on your back, 1 capsule is inserted deep into the vagina in the evening before bedtime. The course of treatment is 12 days.
Preventive course - 6 days.
If one or more doses are missed, treatment should be resumed at the usual dose.
Storage conditions and shelf life
The drug should be stored out of the reach of children at a temperature not exceeding 25 ° C. Shelf life is 2 years.
